On September 7, 2023 Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, reported that management will present at H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023 in New York, NY (Press release, Palatin Technologies, SEP 7, 2023, https://palatin.com/palatin-to-present-at-the-h-c-wainwright-25th-annual-global-investment-conference/ [SID1234634992]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company presentation will be held on Wednesday, September 13, 2023 at 10:00 a.m. ET. A live webcast of the presentation will be available on the Investors section of Palatin’s website at View Source A replay of the webcast will be available for 30 days following the presentation.